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ScarHeterocellular electrotonic coupling between cardiac myocytes and non-excitable connective tissue cells has
been a long-established and well-researched fact in vitro. Whether or not such coupling exists in vivo has been
a matter of considerable debate. This paper reviews the development of experimental insight and conceptual
views on this topic, describes evidence in favour of and against the presence of such coupling in native myocar-
dium, and identiﬁes directions for further study needed to resolve the riddle, perhaps less so in terms of principal
presence which has been demonstrated, but undoubtedly in terms of extent, regulation, patho-physiological
context, and actual relevance of cardiac myocyte–non-myocyte coupling in vivo. This article is part of a Special
Issue entitled "Myocyte-Fibroblast Signalling in Myocardium."
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When we consider the cellular basis of cardiac function, we tend to
focus on myocytes, ‘forgetting’ the seemingly silent majority of electri-
cally non-excitable cells. These include endothelial, fat, immune and
stem cells, but the largest sub-population is formed by connective tissue
cells (ﬁbroblasts). Non-excitable does not mean ‘not exciting’, however,
as these cells are crucial for structural, biochemical, and electro-
mechanical integrity of the heart [1–3].
1.1. ‘The’ cardiac ﬁbroblast?
Until the 1990s, cardiac ﬁbroblasts were largely considered to be of
limited relevance beyond structural support (a bit like the traditional
view on neuroglia). That changed with the discovery of ﬁbroblast-
mediated signalling two decades ago, and led to a step-increase in the
number of publications on cardiac ﬁbroblasts from tens or fewer to
hundreds per year (roughly 99%of all cardiacﬁbroblast papers currently
listed onWeb of Science have been published after 1990). As a result of
this surge, ﬁbroblasts are now accepted as key contributors to develop-
ment, adaptation, and disease-related remodelling of the heart (e.g.
[4–7]). At the same time, we are still far from having comprehensive in-
sight into the roles of connective tissue in the heart. In part, this is
caused by the fact that ‘the’ cardiac ﬁbroblast does not exist.
Cardiac ﬁbroblasts originate from at least three progenitor popula-
tions. Firstly, ﬁbroblasts arise from endocardium via epithelial-to-
mesenchymal transformation [8]. Secondly, retroviral lineage tracing
showed that ﬁbroblasts also originate from the pro-epicardium, a
group of embryonic progenitor cells known to give rise to the epicardi-
um [9]. Thirdly, cardiac ﬁbroblasts derive from bone marrow in normal
development and as a contributor to the homeostatic maintenance of
adult myocardium [10–12], but also during post-injury scar formation
[13]. Fibroblasts therefore constitute a heterogeneous and dynamic
population of cells, whose origin, regulation, and function in health
[14] and disease [15], including their role in repair, impact on cardio-
myocyte proliferation [16] and, possibly, their transformation into
cardiac muscle cells [17], pose exciting challenges of high clinical
relevance. In addition to heterogeneity related to their origin, cardiac
ﬁbroblasts respond to activation, such as during myocardial infarction,
thorough phenotype transformation into myoﬁbroblasts, which are
regarded by some as a distinct cell type altogether (for recent reviews
see [18–21]).
This review is focussed on exploring the presence, in vivo, of electro-
physiologically relevant heterocellular connections between cardiac
myocytes and connective tissue cells. Given that (i) the developmental
origin and (ii) the precise state of cell-activation are not usually
known or reported, and since (iii) neither of these aspects is of primary
concern for exploring the principal question as to whether or not there
is in vivo heterocellular coupling in the heart between the excitable
muscle and the non-excitable connective tissue cells, we will refer to
the latter as ‘ﬁbroblasts’, aware of the inherent limitations of such
abbreviated terminology.
1.2. Properties of ﬁbroblasts in tissue and in a dish
For roughly half a century, the presence of electrotonic coupling
between cardiac ﬁbroblasts and myocytes has been a well-established
fact in vitro. Since the mid-1960s, the synchronization of spontaneous
contractile activity in isolated cardiomyocytes, interconnected solelyby ﬁbroblasts, has been noted and characterised using time-lapse mi-
croscopy, microelectrode recordings, and dye transfer studies [22–24].
More recently, using linearly structured cell cultures [25–28], optical
mapping of voltage sensitive dyes has shown that ﬁbroblast inserts
can electrotonically bridge gaps between groups of myocytes that are
up to 300 μm apart [29].
This ability of ﬁbroblasts to act as long-distance conductors beneﬁts
from their high membrane resistance and relatively low capacitance
[30]. When considering numerical parameter ranges for ﬁbroblast
electrophysiological properties, it is imperative to appreciate pro-
nounced differences between cells in vivo and in vitro (even prior to
electrophysiological remodelling of ﬁbroblasts in cell culture [31]).
Cardiac ﬁbroblasts in vivo form large sheet-like extensions, often
with additional irregular folds, and elongated cytoplasmic processes
[32,33] (not just in mammals; see on-line movie S1 of [34] with data
from ﬁsh). Careful electron microscopy (EM) based reconstruction of
an individual ﬁbroblast in rabbit sino-atrial node revealed that it
formed a membrane juxtaposition with a neighbouring myocyte
covering 720 μm2 [33]. As this reconstruction excluded some of the
more distant ﬁbroblast extensions, total surface area of this cell
will have been 1500 μm2, or more.
In contrast, ﬁbroblasts, freshly-isolated from healthy myocardium,
are rounded cells with initial diameters of about 7–9 μm [31,35,36].
EM data showed that they lack not only the typical membrane exten-
sions, but also folds or membrane invaginations that otherwise could
increase surface area [36]. Therefore, considering their near-spherical
cell shapes, one can calculate the surface membrane area of freshly
isolated ﬁbroblasts as 150–250 μm2, an order of magnitude less than
in tissue. A probable reason for this discrepancy is the fact that cardiac
cell isolation protocols tend to involve a combination of enzymatic
digestion (to destroy connective tissue bonds) andmechanical agitation
(to disturb tissue integrity), with the effect that survivingﬁbroblasts are
likely to be the truncated non-myocyte fragments that contain a nucleus
[37].
Currently, there is no data on the cell size distribution of ﬁbroblasts
in vivo, so we don't know how typical a surface area of 1500 μm2 is for
ﬁbroblasts in the heart. As a ball-park value, though, it is in keeping
with the observation that ﬁbroblast membrane resistances in situ
(0.5–1 GΩ [38,39]) are generally about an order of magnitude lower
than in freshly isolated cells [40,41]. It stands to reason that ﬁbroblast
membrane capacitances in vivo (hard to quantify by direct electrophys-
iological means in these extended and mutually interconnected cells)
exceed those of freshly isolated cells (typically 6–10 pF in ﬁbroblasts
isolated from healthy myocardium [31,41]). Even if that were by an
order of magnitude as well, which is not inconceivable, it would still
render ﬁbroblast capacitances small compared to cardiac myocytes
(values for ventricular cardiomyocytes, isolated from healthy tissue,
range from about 150 pF in rabbit and ferret to 300 pF in rat [42]).
Fibroblasts have a relatively depolarised membrane potential (usual-
ly between -10 and -50 mV; in tissue at the less negative end of this
range), whether recorded using sharp electrodes in situ [38,39], or
using single [43,44] and dual [38,40] patch clamp in vitro. While precise
membrane potential measurements with these direct (but invasive)
electrophysiological techniques are challenging in individual cells when
cell- and seal-resistances are in a similar ball-park, the above potential
range is also evident from observations based on an indirect assessment
of biological reporter systems (e.g. by monitoring ﬁbroblast effects
on cultured cardiomyocytes [45–48]). Therefore, in addition to potential-
ly supporting conduction, cardiac ﬁbroblasts can depolarize resting,
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computational modelling since the mid-1990s has suggested that
this could modulate pacemaker rate and alter excitability of working
cardiomyocytes [38,49] (for the recent state-of-the-art in cardiac
myocyte–ﬁbroblast interaction modelling, see [50,51]), and this has
been corroborated in experimental studies using myocyte–ﬁbroblast
co-culture systems (e.g. [45–48]).
1.3. Scenarios of ﬁbroblast electrophysiological integration
Electrical coupling of cardiac cells is generally thought to be
mediated by gap junctions [52,53], although the possibility of direct
cytosolic links through ‘tunnelling nanotubes’ has recently come to
light [54]. Electrotonic effects of non-excitable cells on cultured
cardiomyocytes can indeed be modulated by altering connexin
expression [55].
Loss or gain of Connexin43 (Cx43) function in ﬁbroblasts can be
achieved by genetic approaches [56]. While Cx43 knockdown or knock-
out provides useful experimental tools for studies of electrical effects of
ﬁbroblasts on myocytes in vitro, this approach may entail complexities
that confound matters in vivo. For example, reduced Cx43 expression
appears to up-regulate ﬁbrosis [57] andmay be associated withmesen-
chymal tumour formation in the heart [58]. In contrast, ﬁbroblasts that
are genetically engineered to overexpress Cx43 appear to have more
benign effects on cultured cardiomyocyte electrophysiology, potentially
offering an anti-arrhythmogenic ‘electrotonic buffer’ [44]. These and
other observations have stimulated research into the potential of
turningﬁbroblasts froma bystander in, or even culprit of, cardiovascular
disease, into a therapeutic target. Indeed, cell-therapeutic approaches
using ﬁbroblasts transfected to overexpress potassium channels
have been used to reduce cardiac automaticity and prolong ventricular
refractoriness in vivo [59].
Based on the topology of ﬁbroblast–myocyte interactions, three
hypothetical types of functionally-relevant coupling effects of ﬁbro-
blasts on the electrophysiology of the intact heart can be proposed
[60]. First, ‘zero-sided coupling’, i.e. ﬁbroblasts not interacting with
myocytes, will separate myocardial cells and/or layers, acting as an
electrical insulator, as indeed will be the effect of the a-cellular part
of cardiac connective tissue. This option is most in keeping with
traditionally-held views, such as pointed out as early as 1906
by Keith and Flack in their original description of the human atrio-
ventricular node [61]. Second, ‘single-sided coupling’ refers to
ﬁbroblasts connected to groups of myocytes that are themselves
well-connected electrically. Here, electrotonic load, or buffer effects
would dominate. Third, ‘double-sided coupling’ refers to ﬁbroblast-
connections that interlink myocytes that are not, or less directly, coupled
electrically. These links are not necessarily afforded just by single
cells, since cardiac ﬁbroblasts are interconnected by homotypic
gap junctions [33,62] that can support ﬁbroblast–ﬁbroblast electro-
tonic coupling in situ, as conﬁrmed by transmission of hyperpolariz-
ing impulses between ﬁbroblasts, 40 μm apart, studied using
double-barrelled microelectrodes in the atria of frog and rat [63,64],
and via dye coupling studies in rabbit [65]. Double-sided coupling
could allow cardiac ﬁbroblasts to form conducting pathways of
electrophysiological relevance at the tissue and organ level. If
conﬁrmed, this case would be of particular interest, as it would
offer novel, therapeutically relevant, insight into post-ablation and
post-infarction electrophysiological behaviour.
This being said, the presence and extent of ﬁbroblast–myocyte
electrotonic coupling in native myocardium (i.e. including observations
in vivo and ex vivo, as long they pertain to cells in a morphologically
intact tissue environment) remain controversial, forming the topic of
this review. We will ﬁrst re-cap the reasons for which one would
doubt the presence of heterocellular coupling in vivo (‘Contra’),
highlight why at least some of these doubts are not without limitations
either (‘Contra-Contra’), review what is known in support of thepresence of heterocellular coupling in the heart (‘Pro’), and ﬁnish by
summarizing what should be done to resolve the riddle (‘Ergo’).2. Contra
There are (at least) three common objections to the view that non-
myocytes may be electrically coupled to muscle cells in native cardiac
tissue.2.1. Heterocellular gap junctions are not normally seen in histological
studies
Generations of histologists have studied cardiac tissue. Intercalated
discs at the juncture of cardiac myocytes were identiﬁed, using EM,
in the early 1950s (e.g. [66]). In the mid-1960s, these disks were
proposed to contain structures that link the cytosol of neighbouring
cardiomyocytes [67] by bridging the gap at the junction of cells [68].
This suggestion was conﬁrmed in the 1970s by puriﬁcation of gap-
junction plaques [69], identiﬁcation in the 1980s of the ﬁrst single
gap-junctional protein capable of linking neighbouring cells via forma-
tion of inter-cellular ion channels [70], and followed up by detailed
characterisation of multiple connexins (Cx), including the major
isoform found in the heart, Cx43 [71]. This triggered signiﬁcant interest
in the role of cardiac gap junctions, including links to other cellular
structures (such as the cytoskeleton [72]). Towards the end of the
1980s, Cx research received a signiﬁcant boost from the introduction
of immunological techniques to identify presence and location of Cx
in various tissues of the body, including heart [73–77]. During the
1990s, Cx distribution studies opened up a treasure chest of insight
into cardiac cell–cell interactions (for a selection of reviews from that
time, see [78–90]) — yet none of the studies suggested a presence of
heterocellular junctions betweenmyocytes and non-myocytes in native
cardiac tissue.2.2. Heterocellular junctions are exceedingly rare, even when speciﬁcally
chased
Following up on early reports on heterocellular coupling in vitro
[22–24,52], and after detailed electrophysiological characterisation of
heterocellular gap-junctional channels connecting freshly isolated or
cultured cell pairs [30,40], the team of Jongsma set out to speciﬁcally
search for gap junctions between myocytes and ﬁbroblasts in native
heart tissue. In a painstaking, serial sectioning based EM study of adult
rabbit sino-atrial node, covering a total area of 7.7 mm2, they observed
just one gap-junction like contact between a ﬁbroblast and a myocyte
[33]. In contrast, small gap junctions between ﬁbroblast pairs were
common, while the analysed tissue volume was estimated to have
contained ~104 gap junctions between cardiac myocytes [33]. Thus,
even targeted EM studies did not support the notion of a regular
presence of heterocellular gap junctions in the heart.2.3. Ockham's Razor: the heart works without invoking heterocellular
coupling
William of Ockham, early 14th century English scholar, stated that,
if there are multiple possible explanations of a phenomenon, the
simplest of them should be preferred. Cardiac electrophysiology
can generally be explained, even in quantitative computational models
[91–102], based solely on considering electrotonic coupling of
myocytes. This shifts the burden of proof: if there is no need to invoke
heterocellular coupling between myocytes and non-myocytes, one
should not do so (never change a winning team).
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3.1. Connexin-based coupling is possible in the absence of detectable gap
junctions
Gap junctions, in particular between cardiac myocytes, lend them-
selves to relatively easy identiﬁcation. Fibroblast gap junctions are signif-
icantly smaller [33], and thus are more easily overlooked. One should
further note that early immuno-histochemical characterisation of
connexin distribution in cardiac tissue did not tend to include any form
of cell labelling. In this setting, intercalated discs between myocytes are
a prominent feature, while the small ‘speckles’ of ﬂuorescence, indicative
ofﬁbroblast-based gap junctions, could easily be regarded as background
noise [103].
What's more, the absence of immuno-histochemically detectable
gap junctions in confocal microscopy studies is not necessarily synony-
mouswith a lack of connexin-based cell coupling, as shown for example
in native arterial smooth muscle [104,105]. Unless super-resolution
optical techniques are used, ﬂuorescently labelled Cx will be detected
only if spatially-clustered, involving at least 80–120 channels [106] (of
note, smaller arrays, containing 15–20 Cx-channels, are regularlyFig. 1. Fibroblast–myocyte interrelations in native cardiac tissue. A: Confocal laser scanning m
CellTracker dye CMFDA. Groups of sino-atrial nodemyocytes (centrally located ‘large’ uniform s
cesses towards themyocytes, seewhite arrows). Outline view left: 158 × 158 μm; detail view r
B: Extended structures, resembling membrane nanotubes (see white arrows), in adult mouse
vimentin (ﬁbroblasts) and α-actinin (myocytes). Scale bar: 10 μm. From [32] in (A), and [54] ipresent in rat ventricular myocardium, as conﬁrmed by EM [106]).
Computer modelling studies suggest that as few as 10–30 connexin
channels would provide sufﬁcient coupling for electrophysiologically
relevant effects of cardiac ﬁbroblasts on myocytes [38]. Possible sites
for such coupling could be ﬁnger-like extensions of cardiac ﬁbroblasts
into the cardiomyocyte basement membrane [32] — points of contact
that may be more frequent in living (Fig. 1A), rather than the ﬁxed
and dehydrated tissue used in most histological analyses.
3.2. Connexin-based coupling may not be necessary for heterocellular cell
junctions
So-called ‘tunneling nanotubes’ [107], membranous channels that
are 50–200 nm wide and that can link cells over distances up to
300 μm in vivo [108], provide an alternative substrate for electrotonic
coupling between different cell types. These structures may either
form connexin-free direct cytosolic links [109], or involve Cx-coupling
at the point of contact of two semi-tubes. The latter could occur
‘anywhere’ along the nanotubular connection, i.e. somewhere between
apparently separate cells. Punctate immuno-labelling (in the absence
of a cytosolic dye) would, in this setting, probably be regarded asicroscopy images of rabbit sino-atrial node live tissue, following diffusion-loading of the
tructures) are intermingledwith cardiac ﬁbroblasts (smaller cells with numerous ﬁne pro-
ight: 30 × 30 μm (corresponds to the area near the arrow at the right edge of the outline).
ventricular tissue. Confocal micrographs of cardiac tissue, labelled for WGA (membranes),
n (B); with permission.
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the presence of nanotube coupling between cardiac ﬁbroblasts and
myocytes has been shown in vitro and in vivo (Fig. 1B; [54]), although
their relevance for cardiac electrophysiological integration remains to
be established.
3.3. Ockham's Razor: special cases
The notion of being able to explain cardiac electrophysiology, based
solely on homocellularmyocyte coupling, is not without limitations. For
example, atrial ablation lines (scars, created to interrupt uncontrolled
excitation waves) often become ‘electrically transparent’ with time,
due to re-emergence of functional conduction pathways [110]. While
this may be due to incomplete lesioning, 10–20% of heart transplant
recipients also show electrical coupling across the (unquestionably
continuous) separation between donor and recipient tissue [111]. Aber-
rant electrical coupling can arise also across suture lines after operations
to ﬁx cardiac birth defects [112]. In all these cases, electrical conduction
crosses scar tissue. Possible explanations include direct ‘touch-and-go’
interaction of survivingmyocytes either side of a cut, de novo generation
of cardiomyocytes that link the two tissue edges, or electrical conduc-
tion via non-myocardial cells such as ﬁbroblasts [62]. Based on the
histological appearance of post-transplantation scar tissue [113], the
last option may offer the most straightforward explanation and,
hence, be in keeping with Ockham.
4. Pro
4.1. Electrotonic ﬁbroblast–myocyte coupling in native tissue
Fibroblasts in native heart tissue at rest have a membrane potential
of -10 to -20 mV when electrically isolated from other cells [38]. They
are electrically non-excitable (though subsequent to long-term cell
culture, expression of the voltage-gated sodium channel Nav1.5 has
been reported in human atrial ﬁbroblasts [114]). Fibroblasts are
excellent ‘followers’ of an electrotonically provided waveform. Thus, if
electrically coupled to a cardiomyocyte, the ﬁbroblast's membrane
potential will show a myocyte-like action potential shape, albeit withFig. 2.Membrane potential pairs (top and bottom), recorded simultaneously in spontaneously b
40 μm) from putative ﬁbroblasts (F, top) and cardiomyocytes (M, bottom). Left: F, electrically n
potential (here about -20 mV) and the contraction-inducedmembrane potential change typica
jacent myocytes, F display an additional, probably electrotonically transmitted membrane depo
potential in F, and a ‘capacitative’ spike (labelled ‘c’) believed to be caused by the synchronous
that would be commensurate with an F that is well-coupled to adjacent cardiomyocytes, wher
duced amplitude and upstroke velocity (here on top of the atrial contraction-inducedmechano-
with permission.a slowed upstroke and reduced amplitude (as illustrated in double
whole-cell patch clamp experiments [40]). The ability of ﬁbroblasts to
passively convey action potentials, together with their high membrane
resistance that supports ‘low-loss’ long-range signal conduction, makes
ﬁbroblasts a tantalising potential conduit for electrotonic signal
transmission.
Unfortunately, this very behaviour also makes it nearly impossible
to conﬁdently explore cardiac ﬁbroblast electrical integration in situ,
using classic electrophysiological techniques [38]. While ﬁbroblasts
that are electrically isolated from cardiac muscle cells can be identiﬁed
by their weakly polarised membrane potential and mechanically-
induced polarizations in the rhythm of tissue contraction, those ﬁbro-
blasts that are well-coupled (and, hence, at the centre of interest here)
are indistinguishable from poorly impaled cardiomyocytes (Fig. 2;
[38]). Nonetheless, indirect support for heterocellular connections in
weakly coupled ﬁbroblasts has been found (Fig. 2, centre; note that
upon electro-mechanical uncoupling of the preparation, the mechani-
cally induced component ‘a’ recedes, while ‘b’ and ‘c’ remain).
4.2. Connexins at ﬁbroblast–myocyte contact sites in cardiac tissue
Immuno-histochemical labelling studies for a range of cardiac
connexins, combined with identiﬁcation of cells on either side of
connexin signals, suggest that Cx-localization at the point of contact
between cardiac ﬁbroblasts and myocytes is far from uncommon, both
in healthy (Fig. 3 [62]) and post-infarct tissue (Fig. 4 [115]).
Of course, presence of a protein ‘in the right place’ does not conﬁrm
its functionality. Direct evidence for heterocellular coupling in native
tissue has thus far been obtained only in rabbit sino-atrial node,
where Lucifer yellow dye transfer between myocytes and ﬁbroblasts
was observed [65].
Clearly, further investigation is needed to explore developmental
dynamics, anatomical distribution, physiological regulation, and
response to disease progression or treatment attempts, but proof-of-
concept for ﬁbroblast–myocyte coupling in vivo has been established.
A conceptual approach to myocardial function that excluded the
possibility of heterocellular coupling would, therefore, be unnecessarily
restricted.eating adult rat atriumusing double-barrelled ﬂoatingmicroelectrodes (tip-to-tip distance
ot connected to surrounding cardiomyocytes, showing a relatively depolarizedmembrane
l for these cells (label ‘a’). Middle: in some cases, presumably whenweakly coupled to ad-
larization (labelled ‘b’) while the myocyte membrane potential is positive to the diastolic
depolarization of myocytes in the proximity of F. Right: recording of a potential waveform
e the electrotonically transmitted component mimics an action potential waveform of re-
sensitive peak; note different potential scales for ﬁrst two F potentials). Adapted from [38];
Fig. 3. Connexin location relative to cardiac myocytes and connective tissue cells in native myocardium of healthy rabbit. Triple immunolabeling for myocytes (M; red: antimyomesin),
ﬁbroblasts (F; blue: antivimentin), and Cx43 or Cx40 (top and bottom rows, respectively; green: anti-Cx43/anti-Cx40) in ventricle, atrium, and atrioventricular node (AVN). Vertical ar-
rows: homotypic myocyte contacts; horizontal arrows: homotypic non-myocyte connections; slated arrows: Cx at heterotypic cell contacts. Side-panels show 2.55× zoomed views of the
areas highlighted by dashed squares in the main images. Note signiﬁcantly smaller size of Cx labels at homo- and heterotypic contact sites that involve non-myocytes. Scale bars: 20 μm.
From [62], with permission.
42 P. Kohl, R.G. Gourdie / Journal of Molecular and Cellular Cardiology 70 (2014) 37–464.3. Optical mapping of conduction inside scar tissue
Given the principal difﬁculty of distinguishing between trans-
membrane potential waveforms of (active) cardiac myocytes and
(passive) ﬁbroblast-followers in normal heart tissue, cardiac scars
offer an interesting alternative study subject, because the ratio of
electrically active and passive cells is shifted signiﬁcantly towards
predominance of the latter. A ﬁne example of such work is the 2007
study of Walker et al., investigating fully-transmural infarcts in adult
rabbit left ventricle by optical mapping of voltage-sensitive dye signals
(Fig. 4A). They observed propagation of cardiac excitation waves
into scar tissue, even after chemical ablation of any surviving sub-
endocardial muscle layers (Fig. 4B), performed to exclude possible
contributions from these deeper myocyte-sheets to epicardially mapped
potentials; [116]). The signals fromwithin the scar resembled ventricular
action potentials, albeit with slowed upstroke and reduced amplitude—
very much in keeping with previous observations in neonatal rat
ﬁbroblast–myocyte cell pairs [40] and adult rat atrial tissue [38].
Subsequent work by other investigators conﬁrmed that excitation
waves can indeed invade and pass through cardiac scar tissue
[118,119]. These studies further showed that the myocyte-like action
potentials inside four-week old ventricular scar tissue in rabbit ventricle
are not accompanied by signiﬁcant cyclic changes in intracellular free
calcium concentration [118]. As calcium transients are a signature activ-
ity of cardiomyocytes, the most straightforward explanation again is
that non-myocytes passively display much of the electrical signals con-
ducted inside scars [117], perhaps electrically integrating surviving
myocyte islands that could act as active ‘repeater stations’ thatmaintain
or boost electrical signal amplitude.
5. Ergo
The short response to the initial question “Fibroblast–myocyte
electrotonic coupling: does it occur in native cardiac tissue?” is: ‘yes’. How-
ever, as will be clear from the above, this raises many more questionsthan it answers. Some of the aspects, relevant for further study, are
summarised below.
5.1. Need targeted assessment of dynamic heterocellular interactions
Conﬁrmation, in native myocardium, of functional ﬁbroblast–
myocyte coupling at the cellular level has been obtained thus far in
healthy atrial tissue of a single species only [65].Whether heterocellular
interactions in vivo change during development, disease, and/or in re-
sponse to therapeutic interventions, and whether they differ between
species and/or cardiac tissue regions, is unknown. Given the presence
of fractional differences in ﬁbroblast origin [8–13], as well as disease-
induced ﬁbroblast phenotype transitions [120], and mechanical modu-
lation of Cx coupling [121], it is reasonable to expect differences in
heterocellular interactions of ﬁbroblasts in diseased tissue, compared
to control [122].
Equally unconﬁrmed is the functional relevance of heterocellular
coupling in in vivo. For example, ﬁbroblasts show cardiac contraction-
related ﬂuctuations in membrane potential [38], probably mediated by
stretch-activated ion channels [123–125] and changes in calcium
handling [126]. Thismay be functionally relevant beyond electrophysiol-
ogy, integrating cardiac electrical andmechanical activity [127]. Another
area of possible functional importance is related to the observation that,
during myocardial infarction, ﬁbroblasts increasingly express functional
KATP channels in scar and border zone tissue [128]. This could be of rele-
vance for arrhythmia prevention and treatment, and lends support to the
suggestion that (pre-/post-)conditioning needs to consider effects on the
whole heart, not just the cardiomyocytes [129].
In addition, it is important to realise that not all scars are created
equal. Oxygen starvation during myocardial infarction, for example,
will affect preferentially the metabolically more active cardiomyocytes,
so that locally-surviving cells (with a bias towards non-myocytes) will
contribute to scar tissue composition. In contrast, ablation by excess
local energy delivery will destroy cells irrespective of their nature (but
potentially dependent on their proximity to circulating normothermic
Fig. 4. Propagation of electrical activation into ventricular scar tissue. A: Epicardially recorded optical maps of trans-membrane potential changes (dye used: RH237) in Langendorff-
perfused rabbit isolated heart, 8 weeks after induction of transmural left-ventricular infraction (see B, left panel). Electrical pacing (at site identiﬁed in the schematic on the left by a
red dot, and in the photograph (i) of the infract area by a white asterisk) in the normal zone (NZ) gives rise to a conduced wave of electrical excitation, which is delayed by about
10 ms at the peri-infarct before invading the infarct zone (PZ, IZ; respectively); see crowding and thinning of activation isochrones (ii). Normalised trans-membrane potential shapes, re-
corded at the locations labelled d–h, are shown in (iii). Signals from inside the scar tissue (i.e. at sites g and h) persisted even after chemical ablation of surviving endocardial muscle layers
(panel B). LA: left atrium, RA: right atrium; LV: left ventricle; red vertical line in (iii): time of pacing stimulus.B:Histological substrate of scar tissue in rabbit (left, 8weeks post-infarct, used
in the experimental studies shown in A) and sheep (border zone at 1 week post infract [middle]; infarct zone 2 weeks post-infarct [right]). The panel on the left (trichrome staining) il-
lustrates the transmural nature of infarcts used in the opticalmapping studies, including thepresence of islands of survivingmyocytes in the infarct zone, and a surviving endocardial tissue
rim (lower edge of section) that was ablated in part of the study. The images in the centre and at the right (triple immuno-labelling for Cx43 [green], myomesin to identify myocytes by
their striation, and vimentin to labelﬁbroblasts [both red]) highlights Cx43 distribution, including presence at heterocellular contact sites at the infract border (middle) and in central zone
myocyte islands. Vertical arrows: homotypic myocyte contacts; horizontal arrows: homotypic non-myocyte connections; slated arrows: Cx43 at heterotypic cell contacts. From [116] in
(A) and from [117,115,1], respectively, in (B);with permission.
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forming the post-ablation scar will invade from intra- or extra-
cardiac sources outside the ablation focus. Yet another setting is ob-
served at surgical suture lines, where the scar is built de novo, in the
absence even of any pre-existing extracellular matrix. Further vari-
ances in electrophysiological properties of atrial vs. ventricular ﬁbro-
blasts [130] may contribute to dissimilar functional behaviours
displayed by different cardiac scars, for example after atrial ablation
or ventricular infarction. And last, but not least, scar tissue is highly
dynamic, containing a range of non-myocyte cell- and phenotypes
whose relative quantities, and Cx expression patterns [115], change
over time with scar maturation.
Scars, of course, are but the tip of the iceberg and it will be impor-
tant to develop an understanding of the roles that ﬁbroblasts may
have as electro-mechanical signalling hubs in normal, and diffusely
or patchy ﬁbrotic tissue. This will require a better understanding of
whole-heart histo-anatomical features, beneﬁtting from imaging-
based 3D reconstruction and biophysically-detailed simulation
[131–134], an area that has made signiﬁcant progress in recent years
in terms of inclusion of connective tissue effects on arrhythmogenesis
[100,135–137] and deﬁbrillation [138,139]. It is vital, though, not to
fall victim of the ‘plausibility trap’ [140]: simply because modelling
and reality ‘agree’with one another does notmean thatmechanisms in-
voked in a theoretical model are crucial, or indeed even involved at all.
Key to progress is validation, and this requires development and appli-
cation of novel experimental tools.5.2. Need better tools
It is evident that, on the one hand, ﬁbroblast–myocyte interactions
in cardiac cell cultures overestimate Cx-coupling while, on the other
hand, native ‘bulk’ tissue studies are associated with signiﬁcant chal-
lenges in terms of electrophysiological identiﬁcation and characterisa-
tion of ﬁbroblast activity and coupling. This calls for intermediate level
biological model systems, such as thin sections of live cardiac tissue.
Cardiac tissue slices were originally established and used as an experi-
mental model for biochemical and pharmacological research (e.g.
[141–143], reviewed in [144]). By now, they have been employed in
electrophysiology research, using extra- and intracellular potential re-
cordings [145] and optical mapping techniques, including dual-dye
(calcium and voltage) studies [146]. They have been tested for a range
of cardiac tissue sources, from neonatal and adult rat to human [147].
Heart tissue slices, usually cut at a thickness of 300–400 μm to prevent
oxygen starvation, allow prolonged maintenance of biological activity
[145,148]. They lend themselves to improved correlation of observed
electrophysiological signals to underlying histological substrates, both
because they are thin enough for visual inspection, and since local sig-
nals are less affected by more distant tissue (e.g. far-ﬁeld potentials for
contact recordings, or depth-effects of photon scattering in opticalmap-
ping of bulk tissue [149]).
In addition to the use of pseudo two-dimensional yet organotypic
models for observation, optical tools for targeted interference offer anoth-
er exciting route to further progress. This has been exquisitely illustrated
44 P. Kohl, R.G. Gourdie / Journal of Molecular and Cellular Cardiology 70 (2014) 37–46by Entcheva and colleagues, who transfected non-excitable cells with a
genetically encoded light-sensitive ion channel (channelrhodopsin-2),
which they used to pace electrotonically connected cardiomyocytes
in vitro [150]. It would be interesting to combine studies like this with
the in vivo engraftment of Cx43-expressing non-excitable cells in scar tis-
sue, which has been found to strongly reduce infarct-related arrhythmias
in mice [151]. In any case, cell-type speciﬁc targeting of optogenetic
probes will open up signiﬁcant potential for novel insight into the multi-
cellular nature of cardiac electrical function.5.3. Need a broader vision of cell coupling in the integrated heart
The need for a broader conceptual approach to heterocellular inter-
actions is evident also from the observation that gap junctions are sites
not only of electrical, but also mechanical integration [152]. Mechanical
interaction of ﬁbroblasts and myocytes could not be illustrated more
vividly than in the ﬁve-day time-lapse movie accompanying Driesens'
beautiful in vitro report on partial cell fusion of rat cardiomyocytes
and ﬁbroblasts [153]. The targeted contacting and mechanical pull of
ﬁbroblasts on myocytes may give rise to mechano-electric feedback
effects of the former on the latter [154], and/or serve as a guide for ﬁbro-
blast cell migration [155]. In addition, it illustrates the highly dynamic
nature of the heterocellular contact points (Fig. 1) between cardiac ﬁ-
broblasts and myocytes (and serves as a note of caution regarding ap-
parent cell-type transitions, in particular in vitro, given the presence of
cell fusion events).
In addition, the ‘perinexus’ [156], a specialised region surrounding
the connexin-dominated part of cell junctions, may support non-
electrotonic ephaptic coupling. Presence of this type of cell interaction
has been proposed in the 1980s [157], and it has recently seen a revival
in terms of interest and insight [158,159].
Finally, when considering the heart as a hetero-cellular organ, we
should not stop atmyocytes and ﬁbroblasts. Electrophysiological effects
of nerve, immune and fat cells, vascular smoothmuscle, or endothelium
(to name but a few), clearly desire a better understanding as well [2,3].6. Heterocellular coupling between cardiac cells in vivo!
There is a growing array of new experimental tools at our disposal to
explore heterocellular coupling in native cardiac tissue. In coming years
it is likely that we will see these tools provide unexpected advances in
our understanding of the electrical interplay between the multiple cell
types that make up the heart. In particular, it is anticipated that there
will be deﬁnitive answers on where and when myocytes and non-
myocytes are capable of electrophysiologically-relevant coupling
in vivo, and what the context and the relevance are of such interactions.
Answers herewill provide new insight into normal cardiac function and
into mechanisms of disease development. Perhaps more importantly,
an understanding of the nature and dynamics of heterocellular electrical
communication in the heart could give rise to novel or improved thera-
peutic approaches. This may range from amendments to established
procedures, such as atrial ablation, to the vision of modifying cardiac
scar properties in a targeted manner to reduce arrhythmogenesis fol-
lowing infarction.
The key question to which we should move on, therefore, is: Fibro-
blast–myocyte electrical coupling: does it matter in native cardiac
tissue?Disclosures
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